Induced oxidative stress and apoptosis by 1-bromopropane in SH-SY5Y cells correlates with inhibition of Nrf2 function

Guangtao Yang1, Wei Zhou1, Minhong Zhang1

  • 1Institute of Occupational Hazard Assessment, Shenzhen Prevention and Treatment Center for Occupational Diseases, Shenzhen, Guangdong, China.

PubMed

Insights

1-bromopropane causes nerve cell damage by increasing oxidative stress and inhibiting the Nrf2 pathway. Vitamin C and Nrf2 activation protect against this neurotoxicity.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • 1-bromopropane (1-BP) is a solvent with potential neurotoxic effects.
  • Oxidative stress and the Nrf2 signaling pathway are critical in cellular defense mechanisms.
  • The specific mechanisms linking 1-BP neurotoxicity to oxidative stress and Nrf2 pathway dysfunction require elucidation.

Purpose of the Study:

  • To investigate the association between oxidative stress, Nrf2 signaling, and 1-BP-induced neurotoxicity.
  • To establish an in vitro model using SH-SY5Y human neuroblastoma cells for studying 1-BP neurotoxicity.

Main Methods:

  • SH-SY5Y cells were exposed to 1-BP to assess neurotoxicity markers.
  • Measurements included reactive oxygen species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD) activity.
  • Nrf2 pathway activation, caspase activity, and apoptosis were evaluated; Nrf2 knockdown and overexpression were performed.

Main Results:

  • 1-BP exposure increased oxidative stress markers (ROS, MDA) and decreased antioxidant enzyme activity (SOD).
  • 1-BP inhibited Nrf2 translocation, reduced Nrf2-regulated gene expression (HO-1, Bcl-2), and induced apoptosis.
  • Vitamin C mitigated 1-BP effects; Nrf2 knockdown exacerbated toxicity, while Nrf2 overexpression offered protection.

Conclusions:

  • 1-BP induces neurotoxicity in SH-SY5Y cells primarily through oxidative stress.
  • Inhibition of the Nrf2 signaling pathway is a key mechanism in 1-BP-induced neurotoxicity and apoptosis.
  • Targeting the Nrf2 pathway may offer therapeutic strategies against 1-BP nerve cell injury.